4 results
Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study
-
- Journal:
- CNS Spectrums / Volume 21 / Issue 5 / October 2016
- Published online by Cambridge University Press:
- 06 April 2016, pp. 393-402
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies
-
- Journal:
- CNS Spectrums / Volume 20 / Issue 2 / April 2015
- Published online by Cambridge University Press:
- 23 June 2014, pp. 140-147
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study
-
- Journal:
- CNS Spectrums / Volume 19 / Issue 4 / August 2014
- Published online by Cambridge University Press:
- 16 December 2013, pp. 330-339
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia
-
- Journal:
- CNS Spectrums / Volume 19 / Issue 2 / April 2014
- Published online by Cambridge University Press:
- 13 December 2013, pp. 197-205
-
- Article
-
- You have access
- Open access
- HTML
- Export citation